New clinical findings show Optavia’s Optimal Weight 5 & 1 Plan preserved 98% of lean mass over 16 weeks, underscoring its focus on metabolic health beyond weight loss. The company positions its ...
Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019) Structured plans, habit building, and dedicated coach ...
According to Research and Markets, the global health coaching market is projected to grow in value from $20.53 billion in 2025 to $22.5 billion in 2026. The ...
Medifast (NYSE:MED) reported first-quarter 2026 results that management characterized as an early step toward stabilizing the ...
Allied Market Research published a report titled," Weight Management Market Size was valued at USD 144.6 billion in 2023 and ...
The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the categoryRandomized controlled trials control ...
Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its own GLP-1 program Tuesday aimed at streamlining access to weight loss drugs, ...
Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...
Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.
Amazon is rolling out a new GLP‑1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to prescription delivery. The company announced on April 21 that Amazon One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results